Zurich, Switzerland
Positrigo, founded in 2018 and headquartered in Switzerland, is addressing a critical gap in the healthcare sector with its motto, "Imaging Everyone." The company operates within the Medical Devices industry, focusing on affordable, accessible solutions for diagnosing dementia in aging societies grappling with nearly a trillion USD in annual costs.
Their flagship product is a brain positron emission tomography system, designed to democratize functional brain imaging by significantly reducing current expenses. This innovation positions Positrigo as a pivotal player at the intersection of cost-effective diagnostic technology and the burgeoning demand for early dementia detection.
In its most recent funding round on April 28, 2023, Positrigo received a grant investment from Innosuisse, underscoring confidence in its mission and potential impact on global health challenges. Investors seeking impactful medical technology innovations may find Positrigo's approach compelling.
Huichuang Medical